Dialyzers, also known as artificial kidneys, used during hemodialysis are fortified with a wide variety of membranes and within both the cellulosic and synthetic classes. Dialyzers are bifurcated into high-flux dialyzers and low-flux dialyzers. Among these, high-flux dialyzers are preferred while performing hemodialysis, as they are efficient and help remove larger molecules while performing dialysis as compared to the low-flux dialyzer.
The considerable rise in the geriatric population and increase in incidence of renal diseases, especially end stage renal disease (ESRD) are the key factors that contribute toward the growth of the global dialyzer market. Further, increase in funding for improved dialysis products and services, surge in incidence of chronic diseases such as diabetes and hypertension, and shortage of kidneys for transplantation are expected to propel the market growth. Although the dialyzer market continues to grow, certain factors hamper the growth of this market. The high cost procedure of hemodialysis and associated complications such as severe anemia and fluid overload is anticipated to hamper the market growth. On the contrary, technological advancements leading to better adoption and opportunities in emerging economies are anticipated to offer growth opportunities for the global dialyzer market.
The dialyzer market is segmented based on type and region. Based on type, the market is divided into high-flux dialyzer and low-flux dialyzer. Based on end user, the market is bifurcated into in-center dialyzer and home dialyzer. Based on region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
- The study provides an in-depth analysis of the global dialyzer market along with the current trends and future estimations to elucidate the imminent investment pockets.
- A comprehensive analysis of the factors that drive and restrict the market growth is provided.
- A comprehensive quantitative analysis of the industry is provided from 2018 to 2025 to assist stakeholders to capitalize on the prevailing market opportunities.
- An extensive analysis of the key segments of the industry helps understand the global trends in the dialyzer market.
- Key players and their strategies are provided to understand the competitive outlook of the industry.
KEY MARKET SEGMENTS
- High-Flux Dialyzer
- Low-Flux Dialyzer
By End User
- In -Center Dialyzer
- Home Dialyzer
o North America
- Rest of Europe
- South Korea
- Rest of Asia-Pacific
- Saudi Arabia
- South Africa
- Rest of LAMEA
KEY MARKET PLAYERS
- Asahi Kasei Corporation
- B. Braun Melsungen AG
- Baxter International Inc.
- Browndove Healthcare (P) Ltd
- Bain Medical Equipment
- Fresenius Medical Care AG & Co. KGaA
- Kawasumi Laboratories Inc.
- Nikkiso Co., LTD.
- Medtronic Plc. (Bellco),
- Jihua Medical Apparatus & Instruments Co., Ltd
- Allmed Medical Care Holdings Limited
- Weigao Group
- China Chengdu Wesley Biotech Co., Ltd
- Toray Industries, Inc.
- Medica Group
- JMS Co. Ltd
- Jiangsu Lengthen Life Science and Technology Co., Ltd
- Medivators, Inc.
What is the estimated value of the Global Dialyzer Market?
What is the growth rate of the Global Dialyzer Market?
What is the forecasted size of the Global Dialyzer Market?
1.2. Key Benefits for Stakeholders
1.3. Key Market Segments
1.3.1. List of players profiled in the report
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
2.2. CXO perspective
3.2. Key Findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Market share analysis, 2017
3.5. Market Dynamics
188.8.131.52. Significant surge in the number of ESRD patients
184.108.40.206. Rise in incidence of diabetes and hypertension
220.127.116.11. Shortage of kidneys for transplantation
18.104.22.168. Risks and complications associated with dialyzers reuse
22.214.171.124. High cost associated with the hemodialysis
126.96.36.199. Technological advancements leading to better adoption
3.6. Patent Analysis (2016-2018)
3.6.1. Patent analysis, by year
3.7. Clinical Trials for Dialyzers
4.1.1. Market size and forecast
4.2. High-flux dialyzer
4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Low-Flux Dialyzer
4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
5.1.1. Market size and forecast
5.2. In-Center Dialysis
5.2.1. Market analysis, by country
5.3. Home Dialysis
5.3.1. Market analysis, by country
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by country
188.8.131.52. U.S. dialyzer market, by type
184.108.40.206. U.S. dialyzer market, by end user
220.127.116.11. Canada dialyzer market, by type
18.104.22.168. Canada dialyzer market, by end user
22.214.171.124. Mexico dialyzer market, by type
126.96.36.199. Mexico dialyzer market, by end user
6.2.3. North America dialyzer market, by type
6.2.4. North America dialyzer market, by end user
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by country
188.8.131.52. Germany dialyzer market, by type
184.108.40.206. Germany dialyzer market, by end user
220.127.116.11. France dialyzer market, by type
18.104.22.168. France dialyzer market, by end user
22.214.171.124. UK dialyzer market, by type
126.96.36.199. UK dialyzer market, by end user
188.8.131.52. Italy dialyzer market, by type
184.108.40.206. Italy dialyzer market, by end user
220.127.116.11. Spain dialyzer market, by type
18.104.22.168. Spain dialyzer market, by end user
22.214.171.124. Russia dialyzer market, by type
126.96.36.199. Russia dialyzer market, by end user
188.8.131.52. Austria dialyzer market, by type
184.108.40.206. Austria dialyzer market, by end user
220.127.116.11. Rest of Europe dialyzer market, by type
18.104.22.168. Rest of Europe dialyzer market, by end user
6.3.3. Europe dialyzer market, by type
6.3.4. Europe dialyzer market, by end user
6.4.1. Key market trends and opportunities
6.4.2. Market size and forecast, by country
22.214.171.124. Japan dialyzer market, by type
126.96.36.199. Japan dialyzer market, by end user
188.8.131.52. China dialyzer market, by type
184.108.40.206. China dialyzer market, by end user
220.127.116.11. India dialyzer market, by type
18.104.22.168. India dialyzer market, by end user
22.214.171.124. Australia dialyzer market, by type
126.96.36.199. Australia dialyzer market, by end user
188.8.131.52. South Korea dialyzer market, by type
184.108.40.206. South Korea dialyzer market, by end user
220.127.116.11. Taiwan dialyzer market, by type
18.104.22.168. Taiwan dialyzer market, by end user
22.214.171.124. Thailand dialyzer market, by type
126.96.36.199. Thailand dialyzer market, by end user
188.8.131.52. Malaysia dialyzer market, by type
184.108.40.206. Malaysia dialyzer market, by end user
220.127.116.11. Indonesia dialyzer market, by type
18.104.22.168. Indonesia dialyzer market, by end user
22.214.171.124. Rest of Asia-Pacific dialyzer market, by type
126.96.36.199. Rest of Asia-Pacific dialyzer market, by end user
6.4.3. Asia-Pacific dialyzer market, by type
6.4.4. Asia-Pacific dialyzer market, by end user
6.5.1. Key market trends and opportunities
6.5.2. Market size and forecast, by country
188.8.131.52. Brazil dialyzer market, by type
184.108.40.206. Brazil dialyzer market, by end user
220.127.116.11. Saudi Arabia dialyzer market, by type
18.104.22.168. Saudi Arabia dialyzer market, by end user
22.214.171.124. South Africa dialyzer market, by type
126.96.36.199. South Africa dialyzer market, by end user
188.8.131.52. Turkey dialyzer market, by type
184.108.40.206. Turkey dialyzer market, by end user
220.127.116.11. Rest of LAMEA dialyzer market, by type
18.104.22.168. Rest of LAMEA dialyzer market, by end user
6.5.3. LAMEA dialyzer market, by type
6.5.4. LAMEA dialyzer market, by end user
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product Portfolio
7.1.5. Business performance
7.2. B. BRAUN MELSUNGEN AG
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product Portfolio
7.2.5. Business performance
7.2.6. Key strategic moves and developments
7.3. BAXTER INTERNATIONAL INC.
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product Portfolio
7.3.5. Business performance
7.3.6. Key strategic moves and developments
7.4. BROWNDOVE HEALTHCARE (P) LTD.
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.5. BAIN MEDICAL EQUIPMENT
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Product Portfolio
7.6. FRESENIUS MEDICAL CARE AG & CO. KGAA
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product Portfolio
7.6.5. Business performance
7.6.6. Key strategic moves and developments
7.7. KAWASUMI LABORATORIES INC.
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segment
7.7.4. Product Portfolio
7.7.5. Business performance
7.8. MEDTRONIC PLC. (BELCO)
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments
7.9. NIKKISO CO., LTD.
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product Portfolio
7.9.5. Business performance
7.10. JIHUA MEDICAL APPARATUS & INSTRUMENTS CO., LTD
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product Portfolio
7.11. ALLMED MEDICAL CARE HOLDINGS LIMITED
7.11.1. Company overview
7.11.2. Company snapshot
7.11.3. Operating business segments
7.11.4. Product Portfolio
7.12. WEIGAO GROUP
7.12.1. Company overview
7.12.2. Company snapshot
7.12.3. Operating business segments
7.12.4. Product Portfolio
7.12.5. Business performance
7.13.1. Company overview
7.13.2. Company snapshot
7.13.3. Operating business segments
7.13.4. Product Portfolio
7.14. CHINA CHENGDU WESLEY BIOTECH CO., LTD
7.14.1. Company overview
7.14.2. Company snapshot
7.14.3. Operating business segments
7.14.4. Product Portfolio
7.15. TORAY INDUSTRIES, INC.
7.15.1. Company overview
7.15.2. Company snapshot
7.15.3. Operating business segments
7.15.4. Product Portfolio
7.15.5. Business performance
7.16. MEDICA GROUP
7.16.1. Company overview
7.16.2. Company snapshot
7.16.3. Operating business segments
7.16.4. Product Portfolio
7.17. JMS CO. LTD.
7.17.1. Company overview
7.17.2. Company snapshot
7.17.3. Operating business segments
7.17.4. Product Portfolio
7.17.5. Business performance
7.18. JIANGSU LENGTHEN LIFE SCIENCE AND TECHNOLOGY CO., LTD
7.18.1. Company overview
7.18.2. Company snapshot
7.18.3. Operating business segments
7.18.4. Product Portfolio
7.19. MEDIVATORS, INC.
7.19.1. Company overview
7.19.2. Company snapshot
7.19.3. Operating business segments
7.19.4. Product Portfolio
7.20.1. Company overview
7.20.2. Company snapshot
7.20.3. Operating business segments
7.20.4. Product Portfolio
The function of the kidneys is to remove waste products and excess fluid from the blood. The process is carried out with the help of dialyzer (hemodialysis) when the kidneys do not function normally. Thereby, a dialyzer is also known as artificial kidney. Waste products, such as urea and creatinine are removed from the blood with the help of artificial and natural semipermeable membranes.
Increase in the number of ESRD patients, rise in incidence of diabetes and hypertension, and surge in funding for improved dialysis products and services drive the growth of the dialyzer market. Moreover, owing to lack of matching donors, dialysis is preferred over kidney transplant, which is expected to further fuel market growth. However, risks and complications associated with dialysis, and product recall are expected to hamper market growth.
Based on type, the high-flux dialyzer segment was the highest contributor toward market growth in 2017 and is expected to maintain its dominance during the forecast period. This is attributed to the fact that more permeable membrane of a high-flux dialyzer allows much faster removal of fluid and is thereby more preferably used as for hemodialysis.
Key Findings of the Dialyzer Market:
Based on type, the high-flux dialyzer segment accounted for nearly half share of the dialyzer industry in 2017.
The home dialyzer segment is anticipated to grow with the highest CAGR throughout the forecast period.
Based on region, North America accounted for a major share of the global dialyzer market in 2017.
Asia-Pacific is anticipated to grow at the highest rate in the dialyzer market during the analysis period, followed by LAMEA.
North America was the leading revenue contributor to the global market in 2017, owing to highly advanced healthcare infrastructure and new product launches by the key players. Asia-Pacific is expected to witness the highest growth rate throughout the forecast period, owing to the increase in awareness among healthcare professional regarding use of home dialyzer for the treatment of kidney failure related diseases.
The report provides a comprehensive analysis of the leading companies operating in the global market such as Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., Browndove Healthcare (P) Ltd., Bain Medical Equipment, Fresenius Medical Care AG & Co. KGaA, Kawasumi Laboratories Inc., NIKKISO CO., LTD., Medtronic Plc. (Bellco), Jihua Medical Apparatus & Instruments Co., Ltd., Allmed Medical Care Holdings Limited, Weigao group, Farmasol, China Chengdu Wesley Biotech Co., Ltd., Toray Industries, Inc., Medica Group, JMS Co. Ltd., Jiangsu Lengthen Life Science and Technology Co., Ltd., Medivators, Inc., and Dialifegroup
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.